Epitomee Competitors

EPIT Stock

929.20 17.20 1.82%

Epitomee Medical competes with Intercure, Sofwave Medical, Bio View, Elbit Imaging, and Endymed; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing Epitomee Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Epitomee Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Epitomee Medical Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Epitomee Medical competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
891.36	929.20	967.04

Details

Intrinsic

Valuation

Low	Real	High
842.43	880.27	1,022

Details

Epitomee Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Epitomee Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Epitomee and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Epitomee Medical does not affect the price movement of the other competitor.

	INCR	SOFW	BIOV	EMITF	ENDY
INCR		-0.44	-0.25	-0.81	0.02	INCR
SOFW	-0.44		0.48	0.55	-0.21	SOFW
BIOV	-0.25	0.48		0.3	-0.61	BIOV
EMITF	-0.81	0.55	0.3		-0.05	EMITF
ENDY	0.02	-0.21	-0.61	-0.05		ENDY
	INCR	SOFW	BIOV	EMITF	ENDY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

EMITF	+ 0.55	SOFW
BIOV	+ 0.48	SOFW
EMITF	+ 0.3	BIOV
ENDY	+ 0.02	INCR

High negative correlations

EMITF	- 0.81	INCR
ENDY	- 0.61	BIOV
SOFW	- 0.44	INCR
BIOV	- 0.25	INCR
ENDY	- 0.21	SOFW
ENDY	- 0.05	EMITF

Risk-Adjusted Indicators

There is a big difference between Epitomee Stock performing well and Epitomee Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Epitomee Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INCR	2.65	(0.82)	0.00	3.69	0.00	0.00	4.91	(5.76)	14.45
SOFW	1.52	0.13	0.00	(2.74)	2.49	(1.56)	5.16	(3.74)	14.75
BIOV	2.91	0.13	(0.01)	(0.11)	3.63	(3.77)	7.92	(5.24)	22.33
EMITF	2.03	0.57	0.13	(0.77)	2.13	(2.68)	6.06	(4.00)	16.02
ENDY	2.68	0.14	0.02	0.51	3.40	(3.59)	4.10	(6.46)	47.62

Unable to evaluate fundamental data of [INCR.TA, SOFW.TA, BIOV.TA, EMITF.TA, ENDY.TA] at this time. Please try again later

All Fundamental Data

Epitomee Medical Competitive Analysis

The better you understand Epitomee Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Epitomee Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Epitomee Medical's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	EPIT	INCR	SOFW	BIOV	EMITF	ENDY
	1.82 929.20 Epitomee	2.79 516.00 Intercure	0.61 1,795 Sofwave	3.56 26.20 Bio	1.51 522.00 Elbit	0.67 297.90 Endymed
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Not too volatile	Very steady	Very steady
Market Performance (90 Days Performance)	OK	Very Weak	Weak	Very Weak	Solid	Insignificant
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Below Average	Low	Below Average	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Cautious Hold	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell
Current Ratio	N/A	0.31 X	N/A	2.14 X	0.29 X	2.58 X
Net Asset	N/A	686.32 M	N/A	40.02 M	72.27 M	19.6 M
Profit Margin	N/A	0.09 %	(0.61) %	0.04 %	N/A	0.14 %
EBITDA	N/A	31.18 M	(15.14 M)	4.72 M	(20.43 M)	3.2 M
Current Valuation	339.18 M	688.06 M	174.37 M	35.4 M	335.88 M	1.85 M
Price To Book	3.48 X	1.43 X	2.19 X	1.72 X	0.73 X	0.70 X
Operating Margin	N/A	0.18 %	(0.62) %	0.02 %	(2.36) %	0.06 %
Retained Earnings	N/A	(35 M)	N/A	(29 M)	(267 M)	(12 M)
Current Asset	N/A	1000 K	N/A	26 M	249 M	9 M
Beta	N/A	-0.22	N/A	0.53	0.89	-0.0864
Number Of Employees	6	350	92	35	4	41
Shares Outstanding	29.58 M	45.57 M	34.15 M	13.75 M	9.19 M	13.76 M
Cash Flow From Operations	N/A	25.02 M	N/A	3.25 M	(3.38 M)	4.63 M
Annual Yield	N/A	N/A	N/A	N/A	0.09 %	N/A
Total Debt	N/A	11.95 M	N/A	2.57 M	280.59 M	463 K
Return On Equity	N/A	0.0736	-0.35	0.0399	-0.25	0.21
Z Score	N/A	27.6	N/A	12.0	-9.0	46.6
Return On Asset	N/A	0.0538	-0.18	0.0091	-0.0522	0.0385
Book Value Per Share	N/A	10.75 X	1.12 X	2.00 X	7.72 X	1.04 X
Current Liabilities	N/A	1000 K	N/A	8 M	595 M	4 M
Total Asset	N/A	686.32 M	N/A	40.02 M	72.27 M	19.6 M
Debt To Equity	N/A	64.90 %	N/A	11.80 %	N/A	7.10 %
Target Price	N/A	40.23	N/A	N/A	N/A	N/A
Last Dividend Paid	N/A	N/A	N/A	N/A	0.5	N/A
Shares Owned By Institutions	20.28 %	11.60 %	22.84 %	N/A	6.25 %	N/A
Market Capitalization	318.32 M	551.89 M	392.36 M	53.86 M	51.49 M	35.42 M
Price To Earning	N/A	590.59 X	N/A	N/A	(40.77) X	N/A
Price To Sales	N/A	1.87 X	10.41 X	1.71 X	16.72 X	1.52 X
Net Income	N/A	4.69 M	N/A	2.18 M	(20.5 M)	5.16 M
Earnings Per Share	N/A	0.74 X	(0.29) X	0.09 X	(2.24) X	0.74 X
Shares Owned By Insiders	56.83 %	37.64 %	53.24 %	51.58 %	28.90 %	58.11 %
Revenue	N/A	219.68 M	25.33 M	30.51 M	N/A	21.78 M
Working Capital	N/A	N/A	N/A	18 M	(346 M)	5 M
Cash And Equivalents	N/A	3.66 M	N/A	17.67 M	42.11 M	5.02 M
Cash Per Share	N/A	0.04 X	N/A	1.24 X	4.58 X	0.39 X
Gross Profit	N/A	102.56 M	16.21 M	17.59 M	N/A	10.06 M
Day Typical Price	933.6	506.33	1793.33	25.93	519.67	297.87
Accumulation Distribution	364.15	30491.29	62.03	9.25	33.08	1.46
Market Facilitation Index	0.0013	1.0E-4	0.0075	0.0026	0.0028	0.0
Daily Balance Of Power	(0.81)	0.4516	(0.38)	1.125	(1.14)	(20.00)
Period Momentum Indicator	(17.20)	14.0	(11.00)	0.9	(8.00)	(2.00)
Rate Of Daily Change	0.98	1.03	0.99	1.04	0.98	0.99
Day Median Price	935.8	501.5	1792.5	25.8	518.5	297.85
Price Action Indicator	(15.20)	21.5	(3.00)	0.85	(0.50)	(0.95)
Coefficient Of Variation	838.36	(401.74)	1812.58	5713.6	596.65	3099.7
Mean Deviation	10.32	2.65	1.52	2.91	2.03	2.68
Jensen Alpha	3.53	(0.82)	0.1319	0.1295	0.571	0.1435
Total Risk Alpha	(1.15)	(1.36)	(0.26)	(0.58)	0.0273	(0.76)
Sortino Ratio	0.6413	N/A	0.0027	(0.01)	0.1268	0.0155
Downside Variance	32.56	N/A	8.09	16.68	8.79	19.27
Standard Deviation	31.76	3.35	2.47	4.13	3.01	6.1
Kurtosis	58.31	(0.16)	3.59	1.66	2.05	35.43
Potential Upside	23.06	4.91	5.16	7.92	6.06	4.1
Treynor Ratio	1.8	3.69	(2.74)	(0.11)	(0.77)	0.5115
Maximum Drawdown	273.98	14.45	14.75	22.33	16.02	47.62
Variance	1008.55	11.2	6.11	17.05	9.06	37.22
Market Risk Adjusted Performance	1.81	3.7	(2.73)	(0.1)	(0.76)	0.5215
Risk Adjusted Performance	0.1009	(0.18)	0.0491	0.0215	0.1356	0.0334
Skewness	7.43	(0.23)	(0.56)	(0)	0.3179	4.92
Semi Deviation	4.27	N/A	2.49	3.63	2.13	3.4
Information Ratio	0.1152	(0.29)	0.0032	(0.01)	0.1249	0.0112
Value At Risk	(7.13)	(5.76)	(3.74)	(5.24)	(4.00)	(6.46)
Expected Short fall	(15.80)	N/A	(1.56)	(3.77)	(2.68)	(3.59)
Downside Deviation	5.71	N/A	2.85	4.08	2.96	4.39
Semi Variance	18.23	N/A	6.18	13.18	4.54	11.55

Epitomee Medical Competition Performance Charts

Five steps to successful analysis of Epitomee Medical Competition

Epitomee Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Epitomee Medical in relation to its competition. Epitomee Medical's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Epitomee Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Epitomee Medical's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Epitomee Medical, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Epitomee Medical position

In addition to having Epitomee Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alternative Energy Thematic Idea Now

Alternative Energy

Large and mid-size companies, ETFs and funds that are either investing or directly involved in providing energy derived from sources not connected to fossil fuels, do not consume natural resources, and do not harm the environment. This includes wind power, nuclear and solar energy, biofuel, ethanol, hydrogen and others alternative sources of energy. The Alternative Energy theme has 42 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Energy Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Epitomee Stock

Epitomee Medical financial ratios help investors to determine whether Epitomee Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epitomee with respect to the benefits of owning Epitomee Medical security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC